- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 9, 2024 | 43.09M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 43.09M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 42.92M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $3.01M |
| Capex | Q1 2024 · Mar 31, 2023 | $2.07M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$7.9M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$3.05M |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $565.69M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $546.85M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $18.36M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $15.35M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$13.94M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $4.07M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $30.89M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $33.69M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $606.8M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $582.54M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $624.85M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $601.53M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $145.31M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $133.98M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $610.91M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $605.59M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.39 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.11 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.39 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.11 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $18.15M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $17.3M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $3.36M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $3.2M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$16.88M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$4.51M |
| Operating Income | Q1 2024 · Mar 31, 2024 | $957K |
| Operating Income | Q1 2024 · Mar 31, 2023 | $11.37M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $38.1M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $47.07M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $42.07M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $43.59M |
| Revenue | Q1 2024 · Mar 31, 2024 | $80.17M |
| Revenue | Q1 2024 · Mar 31, 2023 | $90.66M |
| Revenue restated | Q1 2024 · Mar 31, 2022 | $80.17M |